Treatment decision-making and treatment experiences in men with metastatic castration-resistant prostate cancer

Background and purpose: For the most advanced stage of metastatic castration-resistant prostate cancer (mCRPC), several life-prolonging treatments have become available over the past decade. Treatment decision-making (TDM) and experiences in this phase are yet to be studied. Hence, this study aimed...

Full description

Bibliographic Details
Published in:Acta Oncologica
Main Authors: Sandra Doveson, Per Fransson, Lena Axelsson, Agneta Wennman-Larsen
Format: Article
Language:English
Published: Medical Journals Sweden 2025-03-01
Subjects:
Castration-resistant
communication
decision-making
prostate neoplasm
therapeutics
Online Access:https://medicaljournalssweden.se/actaoncologica/article/view/42748

Internet

https://medicaljournalssweden.se/actaoncologica/article/view/42748

Similar Items